Digital The future of pharmacovigilance – beginning the shift to AI-... In 2023, the pharmaceutical industry saw a surge in innovation.
R&D Integrating pharmaceutical functions: Using quality insights... As the life sciences field becomes more complex, it is apparent that many aspects of product quality and safety processes are inextricably linked
Partner Content Partner Content How automatization keeps drug safety in war-torn Ukraine Unbreakable digital solution for drug safety teams
Partner Content Partner Content 3 Key Reasons to Attend the 5th Drug Safety conference in Lo... Drug Safety
Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety Conference London 2018
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
